| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGA | Common Stock | Options Exercise | $179,400 | +1,992 | +4.1% | $90.06 | 50,429 | 06 Mar 2024 | Direct | |
| transaction | RGA | Common Stock | Sale | $160,934 | -880 | -1.7% | $182.88 | 49,549 | 06 Mar 2024 | Direct | F1 |
| transaction | RGA | Common Stock | Options Exercise | $441,836 | +4,724 | +9.5% | $93.53 | 54,273 | 06 Mar 2024 | Direct | |
| transaction | RGA | Common Stock | Sale | $381,488 | -2,086 | -3.8% | $182.88 | 52,187 | 06 Mar 2024 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGA | Stock Appreciation Right (right to purchase) 2015 | Options Exercise | $0 | -3,926 | -100% | $0.000000* | 0 | 06 Mar 2024 | Common Stock | 3,926 | $90.06 | Direct | F3 |
| transaction | RGA | Stock Appreciation Right (right to purchase) 2016 | Options Exercise | $0 | -9,669 | -100% | $0.000000* | 0 | 06 Mar 2024 | Common Stock | 9,669 | $93.53 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents (i) 1,934 shares sold to pay the exercise price the purchase of common stock, and (ii) 880 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 1,112 shares. |
| F2 | Represents (i) 4,945 shares sold to pay the exercise price the purchase of common stock, and (ii) 2,086 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 2,638 shares. |
| F3 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |